Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO): Gewinn- und Verlustrechnung
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
Umsatz | 31.629.416,194 | 27.984.605,342 | 22.819.784,741 | 21.275.270,682 | 25.905.526,376 |
Herstellungskosten | 4.362.655,815 | 3.848.177,392 | 3.525.247,787 | 3.486.638,89 | 3.741.798,55 |
Bruttoergebnis | 27.266.760,378 | 24.136.427,95 | 19.294.536,954 | 17.788.631,791 | 22.163.727,826 |
▸ Brutto-Marge | 86,21% | 86,25% | 84,55% | 83,61% | 85,56% |
Betriebliche Aufwendungen | 18.670.348,627 | 17.333.295,381 | 14.668.808,642 | 14.443.911,096 | 18.080.090,321 |
Operativer Gewinn/Verlust | 8.596.411,752 | 6.803.132,569 | 4.625.728,312 | 3.344.720,696 | 4.083.637,505 |
▸ Operative Marge | 27,18% | 24,31% | 20,27% | 15,72% | 15,76% |
Zinsen (Netto) | 771.038,087 | 597.718,559 | 471.239,64 | 378.783,423 | 367.462,518 |
▸ Zinsausgaben | 14.349,097 | 5.558,751 | 5.903,776 | 6.491,853 | - |
▸ Zinseinnahmen | 785.387,185 | 603.277,31 | 477.143,416 | 385.275,276 | 367.462,518 |
Andere Ausgaben | 659.824,301 | 231.161,131 | 429.858,262 | -244.988 | -15.208,767 |
Gewinn vor Steuern | 8.707.625,538 | 7.169.689,996 | 4.667.109,69 | 3.968.492,119 | 4.466.308,79 |
Steueraufwand | - | - | - | - | - |
Minderheitenanteil | 996.570,726 | 833.162,981 | 364.673,76 | 62.117,051 | -63.908,761 |
Nettogewinn/-verlust | 7.711.054,812 | 6.336.527,015 | 4.302.435,93 | 3.906.375,067 | 4.530.217,55 |
▸ Netto-Marge | 24,38% | 22,64% | 18,85% | 18,36% | 17,49% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.